This company has been marked as potentially delisted and may not be actively trading. D8 (DEH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DEH vs. ESTA, AVNS, SMTI, INGN, LAKE, ZJYL, AVR, MLSS, NTRB, and APTShould you be buying D8 stock or one of its competitors? The main competitors of D8 include Establishment Labs (ESTA), Avanos Medical (AVNS), Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), Jin Medical International (ZJYL), Anteris Technologies Global (AVR), Milestone Scientific (MLSS), Nutriband (NTRB), and Alpha Pro Tech (APT). D8 vs. Establishment Labs Avanos Medical Sanara MedTech Inogen Lakeland Industries Jin Medical International Anteris Technologies Global Milestone Scientific Nutriband Alpha Pro Tech Establishment Labs (NASDAQ:ESTA) and D8 (NYSE:DEH) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership, valuation and community ranking. Does the MarketBeat Community believe in ESTA or DEH? Establishment Labs received 119 more outperform votes than D8 when rated by MarketBeat users. CompanyUnderperformOutperformEstablishment LabsOutperform Votes11961.98% Underperform Votes7338.02% D8N/AN/A Do analysts rate ESTA or DEH? Establishment Labs presently has a consensus target price of $57.40, indicating a potential upside of 82.51%. Given Establishment Labs' stronger consensus rating and higher probable upside, research analysts plainly believe Establishment Labs is more favorable than D8.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67D8 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor ESTA or DEH? In the previous week, Establishment Labs had 10 more articles in the media than D8. MarketBeat recorded 10 mentions for Establishment Labs and 0 mentions for D8. Establishment Labs' average media sentiment score of 0.69 beat D8's score of -0.73 indicating that Establishment Labs is being referred to more favorably in the media. Company Overall Sentiment Establishment Labs Positive D8 Negative Which has preferable earnings & valuation, ESTA or DEH? D8 has lower revenue, but higher earnings than Establishment Labs. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$166.03M5.46-$78.50M-$2.98-10.55D8N/AN/A-$9.46MN/AN/A Do insiders and institutionals hold more shares of ESTA or DEH? 72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 65.4% of D8 shares are owned by institutional investors. 11.4% of Establishment Labs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is ESTA or DEH more profitable? D8 has a net margin of 0.00% compared to Establishment Labs' net margin of -46.13%. D8's return on equity of 0.00% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-46.13% -184.55% -24.81% D8 N/A N/A N/A SummaryEstablishment Labs beats D8 on 9 of the 13 factors compared between the two stocks. Get D8 News Delivered to You Automatically Sign up to receive the latest news and ratings for DEH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DEH vs. The Competition Export to ExcelMetricD8Surgical Appliances & Supplies IndustryMedical SectorNYSE ExchangeMarket Cap$232.44M$8.59B$5.29B$18.42BDividend YieldN/A1.72%5.12%4.21%P/E RatioN/A18.6621.7331.10Price / SalesN/A70.67379.1626.58Price / CashN/A19.6738.2217.54Price / Book44.924.846.444.30Net Income-$9.46M$284.66M$3.21B$1.02B D8 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DEHD8N/A$5.39-0.4%N/A+1,853.1%$232.44MN/A0.003ESTAEstablishment Labs2.3682 of 5 stars$31.32flat$57.40+83.3%-39.7%$903.46M$166.03M-12.14960Positive NewsGap DownAVNSAvanos Medical3.2195 of 5 stars$11.97-3.5%N/A-33.7%$550.66M$687.80M35.214,040SMTISanara MedTech1.699 of 5 stars$29.50-1.5%$48.50+64.4%-6.9%$262.61M$86.67M-29.8060INGNInogen3.0383 of 5 stars$7.20-1.6%$7.00-2.8%-1.9%$193.59M$335.71M-3.201,030Short Interest ↓Positive NewsLAKELakeland Industries4.88 of 5 stars$15.80-0.9%$27.00+70.9%-1.4%$150.08M$151.82M-175.561,800Analyst ForecastGap DownZJYLJin Medical InternationalN/A$0.86-0.5%N/A-76.9%$135.23M$23.50M0.00245News CoverageAVRAnteris Technologies GlobalN/A$2.94+14.0%$16.50+461.2%N/A$105.91M$2.71M0.00138News CoveragePositive NewsMLSSMilestone Scientific2.0146 of 5 stars$0.97+6.1%$1.25+28.9%+58.0%$75.56M$8.88M-13.8630Analyst ForecastNews CoverageGap DownNTRBNutriband2.9046 of 5 stars$5.03+1.4%$13.00+158.4%+18.0%$55.86M$2.02M-7.0810Gap DownAPTAlpha Pro TechN/A$4.41+3.8%N/A-29.2%$47.95M$57.84M11.92120 Related Companies and Tools Related Companies ESTA Competitors AVNS Competitors SMTI Competitors INGN Competitors LAKE Competitors ZJYL Competitors AVR Competitors MLSS Competitors NTRB Competitors APT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DEH) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding D8 Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share D8 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.